Position in OGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$10,926
+$4,272 QoQ
Shares Held
807
-27.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#342
of 626 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cheviot Value Management, LLC holds $85,375,796 across 9 Drug Manufacturers - General names. OGN ranks #9 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
154,695 | $39,287,889 | |
| 2 | MRK |
Merck & Co., Inc.
|
171,084 | $21,984,294 | |
| 3 | PFE |
Pfizer Inc
|
612,610 | $14,751,648 | |
| 4 | ABBV |
AbbVie Inc.
|
27,894 | $7,019,246 | |
| 5 | AMGN |
Amgen Inc
|
3,892 | $1,409,371 | |
| 6 | LLY |
ELI LILLY & Co
|
581 | $696,868 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,125 | $122,442 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
737 | $93,112 |
All Filings in OGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,926 | 807 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $6,654 | 1,111 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,980 | 1,113 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $12,346 | 1,156 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $11,509 | 1,189 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $21,158 | 1,421 | Shares | Sole | 2025-05-09 | |
| 2021-09-30 | $224,545 | 6,848 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $271,432 | 8,970 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||